EDGAR Filing Documents for 0001477932-17-004409

Form S-3 - Registration statement under Securities Act of 1933:

SEC Accession No. 0001477932-17-004409

Filing Date

2017-09-11

Accepted

2017-09-11 12:45:44

Documents

Document Format Files

Seq	Description	Document	Type	Size
1	FORM S-3	ipix_s3.htm	S-3	222010
2	FORM OF INDENTURE	ipix_ex41.htm	EX-4.1	292836
3	FORM OF COMMON STOCK CERTIFICATE	ipix_ex42.htm	EX-4.2	12413
4	OPINION OF GARY R. HENRIE, ESQ.	ipix_ex51.htm	EX-5.1	26497
5	OPINION OF HOGAN LOVELLS US LLP	ipix_ex52.htm	EX-5.2	18798
6	CONSENT OF BAKER TILLY VIRCHOW KRAUSE	ipix_ex231.htm	EX-23.1	1286
7		ipix_ex52img1.jpg	GRAPHIC	3077
	Complete submission text file	0001477932-17-004409.txt		579380

Mailing Address 100 CUMMING CENTER SUITE 151-B BEVERLY MA 01915

Business Address 100 CUMMING CENTER SUITE 151-B BEVERLY MA 01915 978-921-4125

Innovation Pharmaceuticals Inc. (Filer) CIK: 0001355250 (see all company filings)